Skip to main content

Advertisement

SpringerLink
Log in

The effects of mesenchymal stromal cells and platelet-rich plasma treatments on cutaneous wound healing: ignoring the possibility of adverse events and side effects could compromise study results

  • Research Letter
  • Published:
Archives of Dermatological Research Aims and scope Submit manuscript

Abstract

Common medical events may be associated with decreased immunologic activity and dysregulation of functional epithelial and neuronal tissues caused by growth factors and vesicle secretion by stem and somatic cells. Systemic injection of MSCs has been shown to reduce the immune response mainly through paracrine mechanisms, but some points related to the possibility of adverse events and side effects should be clarified. Flow cytometry for at least 20 cell markers is crucial to assess cell senescence and overall cell viability. Thus, adverse events and unreasonable expectations from cell therapy can be prevented. We believe that by using the precision cell phenotyping kits in clinical trials, many undesirable side effects related to misconceptions about the origin of the cells can be avoided.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Data availability

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Ramos-Gonzalez G, Salazar L, Wittig O et al (2023) The effects of mesenchymal stromal cells and platelet-rich plasma treatments on cutaneous wound healing. Arch Dermatol Res 315:815–823. https://doi.org/10.1007/s00403-022-02451-y

    Article  CAS  PubMed  Google Scholar 

  2. Viswanathan S, Shi Y, Galipeau J et al (2019) Mesenchymal stem versus stromal cells: International Society for Cell and Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy 21(10):1019–1024. https://doi.org/10.1016/j.jcyt.2019.08.002

    Article  CAS  PubMed  Google Scholar 

  3. Maksimova NV, Michenko AV, Krasilnikova OA et al (2022) Mesenchymal stromal cell therapy alone does not lead to complete restoration of skin parameters in diabetic foot patients within a 3-year follow-up period. BioImpacts 12(1):51–55. https://doi.org/10.34172/bi.2021.22167

    Article  PubMed  Google Scholar 

  4. Baranovskii DS, Klabukov ID, Arguchinskaya NV et al (2022) Adverse events, side effects and complications in mesenchymal stromal cell-based therapies. Stem Cell Investig 9:7. https://doi.org/10.21037/sci-2022-025

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research received no external funding.

Author information

Authors and Affiliations

  1. Department of Regenerative Medicine, National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation, Koroleva St. 4, 249036, Obninsk, Russia

    Ilya Klabukov, Elena Yatsenko & Denis Baranovskii

Authors
  1. Ilya Klabukov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Yatsenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Denis Baranovskii
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

IK, EY, DB wrote the main manuscript text. All authors reviewed and approved the manuscript.

Corresponding author

Correspondence to Ilya Klabukov.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klabukov, I., Yatsenko, E. & Baranovskii, D. The effects of mesenchymal stromal cells and platelet-rich plasma treatments on cutaneous wound healing: ignoring the possibility of adverse events and side effects could compromise study results. Arch Dermatol Res 316, 35 (2024). https://doi.org/10.1007/s00403-023-02783-3

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00403-023-02783-3

Keywords

Search

Navigation